Annie Deck-Miller

Great energy and ideas around this collaboration. So excited for what is to come!!

📣 Join Dr. Onel, one of the featured speakers, for the next Prevent Cancer Dialogue webinar on June 4!

He’ll speak on breaking barriers to clinical trial access in a panel on diversifying participation.

🕐 1–3 p.m. ET | 💻 Free + CME credits

Register: preventcancer.org/events/preve...

ASCO 2025 Highlights: Menin Inhibitor for Acute Myeloid Leukemia; Organ Transplant and Checkpoint Inhibitors BUFFALO, N.Y. — Faculty from Roswell Park Comprehensive Cancer Center are among the international experts invited to share their research findings at the American Society of Clinical Oncology (ASCO) a...

Good morning, #ASCO25! Our team's abstracts today look at corticosteroids and CAR T, demographics and outcomes in GI cancers, overcoming disparities in assessment for genetic cancer syndromes, #immunotherapy and quality of life: www.roswellpark.org/newsroom/202...

👏 to Roswell Park fellow Dr. Zunairah Shah for her #ASCO25 talk on differences in how race may influence response to common therapies for metastatic #breastcancer. An extra hand to session co-moderator @yabdoumd.bsky.social and to Dr. Shah's mentor, Dr. Shipra Gandhi – Roswell Park fellowship grads!

Hope is on the horizon for people with glioblastoma and some other cancer types: A promising treatment developed at Roswell Park is moving forward in a national clinical trial after encouraging early results.

Learn more about SurVaxM: www.roswellpark.org/newsroom/202...

Applause to the Roswell Park teams that presented new #cancerresearch at today’s #AACR25 sessions – and thank you to the program alumni who stopped to reconnect! #innovationforimpact

www.roswellpark.org/newsroom/202...

Roswell Park trainees past and present making us proud at #AACR25 😎👏

Still time to catch our a.m. sessions at #AACR25: 3837 on a new way to treat localized #prostatecancer, 4800 on anti-CD19 CAR T in B-cell cancers, 4897 on biomarkers in Black #breastcancer survivors, 6713 on lineage plasticity in prostate cancer, CT137 improving response to immunotherapy in #NSCLC

Rodney Haring, PhD, MSW, speaking at #AACR25 symposium on cancer disparities research in the era of precision medicine: “Precision medicine is based on culture and who we are…. It’s based on being part of the entire research paradigm from start to finish. It has to come from everybody.”

We’re proud to share that our President and CEO, Dr. Candace S. Johnson, has received the “Distinguished Citizen Award” from the Great Falls Council, Scouting America.

Please join us in congratulating Dr. Johnson on this well-deserved honor!

#AACR25: One more hour to catch postdoc Dr. Dongbo Xu presenting abstract 5154, on an effective model for urothelial #bladdercancer, and graduating PhD candidate Mohammed Alruwaili sharing abstract 5991 on a new 3-drug combination strategy for #colorectalcancer and some other p53-mutant cancers.

I really enjoyed catching up with so many colleagues from Roswell Park and from other cancer centers. See you again soon!

Dr. Rodney Haring was honored to be part of an excellent discussion today at #AACR25 on effective ways to address cancer in Indigenous populations, along with Drs. Dorothy Rhoades and Krystal Tsosie. Thank you to all who joined the conversation!

Great to see old friends and learn about new research advances today at #AACR25, the annual meeting of the @theaacr.bsky.social, dedicated to cancer research that makes a difference. Say hi if you are here in Chicago!

Don’t miss Roswell Park’s Dr. Sayan Chakraborty at #AACR25!

“Targeting agrin is expected to fill a major gap in boosting the effectiveness of EGFR therapies, thereby reducing the risk of lung cancer relapse.”

🚨Happening today!

Join Roswell Park’s Dr. Scott Olejniczak, as he presents his late-breaking research at an upcoming session at #AACR25!

🚨 Headed to #AACR25?

Don’t miss Roswell Park’s Dr. Gokul Das presenting late-breaking research this Sunday, 4/27!

Learn more about our presence at this year's @theaacr.bsky.social Annual Meeting: www.roswellpark.org/newsroom/202...

You leave us with wonder, love and gratitude — but also the deep soul and wisdom that ran as a steady current underneath each column. We’re grateful to you, Sean, and will miss you. Be well, and happy trails to you!

Just about a week to go to #AACR25! Say hello if you will be there too — and check out the presentations coming from @roswellpark.bsky.social experts on exemplars in Indigenous cancer health, plus insights from new research in #breastcancer, #lungcancer and #multiplemyeloma.

I loved getting to learn more about Dr. Grant ("Call me Ellen!" she would say) through this conversation. Here's to all the trailblazers and those who lit lamps or cleared the way before them!

Dr. Renier Brentjens will speak on CAR T-cell therapy for solid tumors at @sitcancer.bsky.social Spring Scientific Meeting.

Catch his talk on March 13 at 1:20 PM in Session V: Tumor Microenvironment.

View the full schedule here: www.sitcancer.org/education/sp....

Investigators Focus on Reducing On-Target, Off-Tumor Toxicities With CAR T-Cell Therapy in Solid Tumors Renier Brentjens, MD, PhD, details solid tumors his laboratory is investigating CAR T-cell therapy in and ways to mitigate on-target, off-tumor toxicities.

Investigators Focus on Reducing On-Target, Off-Tumor Toxicities With CAR T-Cell Therapy in Solid Tumors
@roswellpark.bsky.social #oncology
www.onclive.com/view/investi...

Sarah Werner, MD, and Nicole Gaulin, MD, will be presenting at the #SGO2025 Annual Meeting on Women’s Cancer!

This gathering brings together experts in #gynecologiconcology to collaborate, network, & explore groundbreaking science that’s shaping the future of care for patients.

Don't miss @sghmd.bsky.social on WNY Living this Saturday morning on WGRZ- Channel 2, Buffalo! 📺

She’ll be sharing exciting advances in stem cell transplants and how this approach is changing cancer treatment.

Tune in 3/8 at 10:00 AM and learn more! ⏰

Roswell Park Helps Patient Overcome Life-Threatening Illness Through Groundbreaking Treatment CAR T-cell therapy, an emerging personalized cancer treatment, is offering patients new hope for the possibility of long-term remission. Roswell Park is at the forefront of this new approach, with one...

Winding down my #WorldCancerDay thinking of Chris and the progress his experience represents. “I feel great, and I'm back to the life that I knew before.” Amazing and inspiring! @roswellpark.bsky.social

For #WorldCancerDay, we recognize that every patient is different, every treatment is different, but every patient is part of a community that knows what it takes to persevere.

Check out stories of how cancer patients are #UnitedbyUnique: www.roswellpark.org/cancertalk/2...

🧬 New Hope for Hard-to-Treat Prostate Cancer.

Roswell Park researchers led by Dhyan Chandra, PhD, have uncovered a potential weakness in neuroendocrine #prostatecancer: the mitochondrial unfolded protein response (UPRmt).

📖 Read more: www.roswellpark.org/newsroom/202...

Roswell Park Team Identifies New Cause of Chemotherapy Resistance in Triple-Negative Breast Cancer Laboratory research led by Anna Bianchi-Smiraglia, PhD, reveals therapeutic target in metabolic enzyme IMPDH2.

@roswellpark.bsky.social Team Identifies New Cause of Chemotherapy Resistance in Triple-Negative Breast Cancer #breastcancer #oncology

www.onclive.com/view/roswell...

Packing a powerful punch: Benefits of broccoli may keep cancer at bay Isothiocyanates, found in cruciferous vegetables like broccoli, can prevent cancer cells from dividing and cause them to self-destruct through a process called apoptosis.

🤔Can eating broccoli prevent cancer from returning?🥦

Research by our Roswell Park experts show that eating cruciferous vegetables- like broccoli, could help prevent early-stage bladder cancer from coming back.

💡Learn more about our research: www.roswellpark.org/cancertalk/2...

💡 Up to 30% of cancers are fueled by KRAS gene mutations, making them harder to treat — but new advancements are changing that.

Learn more: www.roswellpark.org/cancertalk/2...